8-K ·Filed May 4, 2026

MASI

MASIMO CORP
BULLISH
Impact 8/10
Horizonmonths Processed5mo ago SEC0001104659-26-054512
8-K context-dependent: Items 7.01
Actionable Insight ▲ Bullish

The stock is likely to trade near the $180 offer price as the merger advances. Monitor for regulatory clearance updates and any material conditions to closing. Consider arbitrage opportunities if the spread widens.

DirectionBullish
Confidencehigh
Horizonmonths
Latest settled — T+20d
MASI ▲ +0.39% at T+20d
LONG call ✓ call won +0.39% · α vs SPY -5.26% · entry $177.90 → $178.59
Next anchor: T+60d due 2mo ago
Latest observation: T+28 -9.95% FF3 residual α
Entry anchored
May 4, 2026
via day open
T+1d
+0.11%
call +0.11% · α -0.69%
$178.09
settled 5mo ago
T+5d
+0.10%
call +0.10% · α -2.83%
$178.08
settled 5mo ago
T+20d
+0.39%
call +0.39% · α -5.26%
$178.59
settled 4mo ago
T+60d
—
call — · α —
—
due 2mo ago

Price Chart

Loading chart...

Executive Summary

Masimo shareholders overwhelmingly approved the acquisition by Danaher Corporation for $180.00 per share in cash, with 99.95% of votes cast in favor. The merger is expected to close in 2026, subject to regulatory approvals, and represents a clear path to the deal's completion.

Key Facts

  • Shareholders voted 36,981,681 for vs. 17,061 against on the merger adoption proposal
  • Merger consideration: $180.00 per share in cash, no interest
  • Quorum of 70.68% of outstanding shares represented at special meeting
  • Merger expected to close in 2026, subject to customary conditions including regulatory approvals

Financial Impact

All outstanding shares to be converted to $180 cash per share, implying an equity value of approximately $9.4 billion based on 52.36 million shares outstanding.

stock pricedeal value

Risk Factors

  • Regulatory approvals may not be obtained or could impose conditions
  • Deal termination or renegotiation if conditions are not satisfied
  • Timing of closing could extend into 2027

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
40% bullish (15 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-054512
Document: tm2612557d3_ex99-1.htm0001104659-26-054512
Document: 0001104659-26-054512-index-headers.html0001104659-26-054512
Document: 0001104659-26-054512-index.html0001104659-26-054512
Document: 0001104659-26-054512.txt0001104659-26-054512
9 reports for MASI
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+60▲ +1.94%Feb 27, 2026
Filters
Rows
Reports for MASI — sortable, filterable
TypeNow
Jun 22, 2026
14w ago
15-12G
NEUTRAL ★ 4/10
—awaiting T+5——
Jun 10, 2026
16w ago
8-K
BULLISH ★ 8/10
$179.95 $179.95· 0.00%▼ −2.14%—
May 4, 2026
21w ago
8-K
BULLISH ★ 8/10
$177.90 $178.08▲ +0.10%▼ −2.83%—
Apr 21, 2026
23w ago
Court Ruling
BEARISH ★ 6/10
$178.21 $178.10▲ +0.06%▲ +1.15%—
Apr 1, 2026
26w ago
DEFM14A
BULLISH ★ 8/10
$177.95 $177.88▼ −0.04%▼ −3.80%—
Mar 18, 2026
28w ago
PREM14A
NEUTRAL ★ 4/10
$178.51 $176.87▼ −0.92%▲ +1.29%—
Feb 27, 2026
30w ago
DFAN14A
BULLISH ★ 9/10
$175.27 $175.42▲ +0.09%▲ +1.29%—
Jan 23, 2026
36w ago
Court Ruling
NEUTRAL ★ 2/10
$140.64 $137.02▼ −2.57%▼ −2.96%—
Jan 23, 2026
36w ago
Court Ruling
NEUTRAL ★ 2/10
$140.64 $137.02▼ −2.57%▼ −2.96%—
Showing 9 of 9

US Market Status

Market Closed — Opens Mon (64h 16m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access